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Abstract
Background: Plasmodium vivax and Plasmodium falciparum are the major causative agents of malaria. While 
knowledge of the genetic structure of malaria parasites is useful for understanding the evolution of parasite virulence, 
designing anti-malarial vaccines and assessing the impact of malaria control measures, there is a paucity of information 
on genetic diversity of these two malaria parasites in Pakistan. This study sought to shed some light on the genetic 
structure of P. vivax and P. falciparum in this understudied region.
Methods: The genetic diversities of P. vivax and P. falciparum populations from the densely populated, malaria-endemic 
Bannu district of Pakistan were evaluated by analysis of their merozoite surface protein (msp) genes by PCR-RFLP. 
Specifically, the Pvmsp-3α and Pvmsp-3β genes of P. vivax and the Pfmsp-1 and Pfmsp-2 genes of P. falciparum were 
analysed.
Results: In P. vivax, genotyping of Pvmsp-3α and Pvmsp-3β genes showed a high level of diversity at these loci. Four 
distinct allele groups: A (1.9 kb), B (1.5 kb), C (1.2 kb), and D (0.3 kb) were detected for Pvmsp-3α, type A being the most 
prevalent (82%). Conversely, amplification of the P. vivax msp-3β locus produced two allele groups: A (1.7-2.2 kb, 62%) 
and B (1.4-1.5 kb, 33%), with 5% mixed-strain infections. Restriction analysis of Pvmsp-3α and Pvmsp-3β yielded 12 and 8 
distinct alleles, respectively, with a combined mixed genotype prevalence of 20%. In P. falciparum, all three known 
genotypes of Pfmsp-1 and two of Pfmsp-2 were observed, with MAD20 occurring in 67% and 3D7/IC in 65% of the 
isolates, respectively. Overall, 24% P. falciparum samples exhibited mixed-strain infections.
Conclusion: These results indicate that both P. vivax and P. falciparum populations in Pakistan are highly diverse.
Background
Malaria is a major threat to the public health and eco-
nomic development of many nations. While Plasmodium
falciparum  causes most malaria-induced mortality
worldwide,  Plasmodium vivax is the major cause of
malaria morbidity outside Africa [1]. Plasmodium vivax
has historically been largely neglected in control, partly
because of its lower virulence than P. falciparum [2].
However, recent studies from Indonesia, Papua New
Guinea, Thailand and India have shown that as high as
21-27% of patients with severe malaria have P. vivax
monoinfection [3].
Pakistan is endemic for both P. vivax and P. falciparum
malaria [4,5]. The prevailing extensive agricultural prac-
tices, an expansive irrigation network, and the monsoon
rains act together to promote a favourable environment
for malaria transmission in many areas of Pakistan.
According to the World Health Organization (WHO),
97% (approximately 150 million) of the Pakistani popula-
tion is at risk of contracting malaria, with an estimated
nationwide burden of 1.6 million cases per year [6].
Malaria transmission in Pakistan is markedly seasonal
and prone to epidemic outbreaks in particular geographi-
cal areas, especially the North-West Frontier Province
(NWFP), the Balochistan province and the Sindh prov-
ince [7]. The main malaria transmission season is Sep-
tember through November, following the monsoon
season. However, malaria transmission occurs perenni-
* Correspondence: fbaliraine@daad-alumni.de
2 Department of Medicine, Division of Infectious Diseases, University of 
California - San Francisco, P.O. Box 0811, San Francisco, CA 94143-0811, USA
Full list of author information is available at the end of the articleKhatoon et al. Malaria Journal 2010, 9:112
http://www.malariajournal.com/content/9/1/112
Page 2 of 10
ally along the Western border and coastal areas of the
country. There is a brief transmission season during
spring (March-April), but most of the spring cases are
believed to be delayed expressions of infections acquired
after the monsoon season or relapsing P. vivax malaria
[7]. Overall, P. vivax accounts for 75%, while P. falciparum
accounts for 25% of the malaria burden in Pakistan [7].
Plasmodium vivax infection is usually treated with
chloroquine, but parasites are often inadvertently
exposed to sulphadoxine-pyrimethamine, the commonly
used drug for chemoprophylaxis and treating uncompli-
cated falciparum malaria. Indeed, high frequencies of
antifolate resistance-conferring mutations are detected in
the P. vivax dihydropteroate synthase (Pvdhps) and dihy-
drofolate reductase (Pvdhfr) genes [8-11]. The emergence
of drug resistance and increased virulence in P. vivax
warrants the attention of public health practitioners to
both species. Parasite diversity plays a key role in para-
site's survival strategies, including the potential for
recombination, clonal expansion, gametocyte produc-
tion, drug resistance, and immune response evasion
[12,13]. Studies of the population structure of malaria
parasites are, therefore, essential for understanding the
evolution of parasite virulence and the role of parasite
diversity in malaria transmission, and for designing con-
trol tools, including vaccines, as well as evaluating the
impact of malaria control measures [14,15].
In this study, the genetic diversities of P. falciparum and
P. vivax isolates from a malaria-endemic region in the
North-West Frontier Province of Pakistan were analysed.
Merozoite surface protein (msp) is one of the proteins of
the erythrocytic stage of the parasite's life cycle. Plasmo-
dium falciparum msp-1, msp-2, and P. vivax msp-3 are
involved in helping the parasite escape the host's immune
responses, and are potential targets for vaccine develop-
ment [16]. Pfmsp-1 has three distinct allelic families: K1,
MAD20 and RO33, while Pfmsp-2 has two distinct fami-
lies, 3D7/IC and FC27 [17]. Pvmsp-3, particularly Pvmsp-
3α, is a candidate molecule for inclusion in a P. vivax vac-
cine [16,18]. Pvmsp-3α  and  Pvmsp-3β  have also been
used as markers in population genetic studies worldwide
[19-22]. The best strategy for detecting genetic diversity
is to analyse more than one marker gene, because then
the probability that different clones share the same geno-
type by chance is substantially reduced [23]. Accordingly,
i t  i s  s u g g e s t e d  t h a t  a n a l y s i s  o f  b o t h  Pvmsp-3α  and
Pvmsp3β genes of P. vivax enables greater capacity in
identifying parasite haplotypes and detecting mixed
strain infections [19,20]. For the same reason, both
Pfmsp-1 and Pfmsp-2 genes are often analysed in the case
of P. falciparum.
Since immunity to malaria is strain-specific, character-
ization of polymorphism in msp antigens among natural
populations in different geographical regions should be
conducted to identify the widest possible range of poten-
tial vaccine targets [14,24]. While genetic diversity stud-
ies involving vaccine-candidate genes have been widely
carried out in neighbouring India [14], Iran [25], Afghan-
istan [26] and other parts of the world [24], there is a
dearth of information on the genetic structure of P. vivax
and P. falciparum in Pakistan [27]. This study sought to
examine genetic polymorphisms among Pakistani
malaria isolates and compare diversities and allele types
with those reported from other parts of the world. Specif-
ically, polymorphisms of the Pvmsp-3α  and  Pvmsp-3β
genes in P. vivax, and Pfmsp-1 and Pfmsp-2 genes in P. fal-
ciparum isolates from Pakistan were assessed.
Methods
Study area, sample collection and DNA preparation
The study was carried out in Bannu district (32 ° 43' - 33 °
06' N; 70 ° 22' - 57' E, Figure 1), North-West Frontier
Province (NWFP), Pakistan. This populous district (552
persons/Km2) is listed among the most malaria-afflicted
areas in Pakistan [4]. The Kurram and Gambila rivers tra-
verse Bannu district and provide water for irrigation as
well as, inevitably, forming breeding grounds for malaria
vectors. The main mosquito vectors are Anopheles culici-
facies and Anopheles stephensi [7,28], and the annual par-
asite incidence (API) is in the range of 1.6 - 3.5 per 1000
population, which is substantially above the national
average (0.8 per 1,000 population) [7]. Mean daily tem-
peratures range between 10.8°C - 32.9°C. The area experi-
ences two rainy seasons: in March and during the
summer monsoon that occurs in July and August.
Malaria transmission peaks following the monsoon sea-
son [28]. The district has great economic significance,
Figure 1 A map of Pakistan showing the sampling area. The map 
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being the central market of the Southern Region, in addi-
tion to serving as a safe shortcut to markets in Central
Asia.
Participants were recruited from the Bannu Women
and Children Hospital (BWCH) from July through Octo-
ber 2007. The hospital's catchment area covers the entire
district. Inclusion criterion was consenting to participate
in the project by symptomatic malaria patients visiting
the Malaria Control Program of BWCH, irrespective of
age or sex, while exclusion criterion was non-consent.
After obtaining informed consent, ~200 μl of blood was
collected on Whatman 3MM filter papers by finger-prick.
Concurrently, thick and thin smears were prepared and
stained with Giemsa for subsequent microscopic exami-
nation. Parasite DNA was extracted from filter papers
using the Chelex method and infections diagnosed by a
species-specific nested polymerase chain reaction (PCR)
method as previously reported [29]. Positive controls
were MR4 clones MRA-340G, MRA-343G, 3D7 and HB3,
while sterile water was used as the negative control. Pre-
vious work on the same samples indicated that PCR is
s u pe r i o r  t o  m i c r o s c o p y  i n  d i a g n o s i n g  m a l a r i a  [ 8 ] .  T h e
PCR results based on these samples showed that 1.8%,
60.5%, 22.8% and 14.9% of the samples (n = 114) had P.
falciparum  only,  P. vivax only, mixed vivax-falciparum
infections, and parasite-free, respectively, while the
microscopy method misdiagnosed ~15% of the cases and
also failed to detect mixed-species infections [8]. The
same samples have been utilized to study the population
structure of the two main malaria parasite species in the
Bannu district of Pakistan. The study was approved by
the Institutional Review Board of Quaid-i-Azam Univer-
sity, Pakistan.
PCR-RFLP analysis of Pvmsp-3α and Pvmsp-3β genes in P. 
vivax
Amplification of Pvmsp-3α  and  Pvmsp-3β  genes of P.
vivax and restriction digestion of the resultant amplicons
were carried out following previously reported protocols
[19,20,30], with some modifications. Briefly, using primer
sets and cycling conditions listed in Table 1, nested PCR
was used to amplify the Pvmsp-3α gene, in 25.0 μl reac-
tion volumes. The primary reaction mix comprised of
19.0 μl of 1.1× PCR master mix (Thermo Scientific
ABgene, Rochester, NY); 1.0 μl of each primer (10 μM),
0.5 μl of MgCl2 (25 mM), 0.5 μl of Taq polymerase (5 U/μl;
Invitrogen, Carlsbad, CA) and 3.0 μl of DNA template.
The secondary reaction comprised of 18.0 μl of 1.1× PCR
master mix, 2.0 μl of each primer (10 μM), 0.5 μl of
MgCl2 (25 mM), 0.5 μl of Taq polymerase (5 U/μl) and
2.0 μl of the primary reaction amplicon.
For RFLP analysis, 6 μl of each PCR product was
digested with 2 units of HhaI and AluI for Pvmsp-3α, and
Pst I for Pvmsp-3β, in 16 μl reaction volumes at 37°C for 4
hrs, following the enzyme manufacturer's protocol (New
England Biolabs, Ipswich, MA). Two enzymes (HhaI and
AluI) were used for Pvmsp-3α because this strategy has
been shown to improve the sensitivity of detecting diver-
sity at this locus [19,31]. Specifically, as clearly illustrated
by the works of Bruce et al [19] and Kim et al [31], owing
to differences in discriminatory power, it is possible for
the restriction pattern of one enzyme to show two iso-
lates as being identical, while the RFLP patterns of the
second enzyme reveals two different alleles; in which case
the combined tally of the number of alleles would be two,
rather than one.
Except for the primers (Table 1), the same primary and
secondary conditions as those for Pvmsp-3α were used
for the amplification of Pvmsp-3β. DNA fragments were
visualized under UV illumination after electrophoresis in
ethidium bromide-stained 1.8% agarose gels. Alleles were
classified based on undigested PCR product size and
RFLP banding patterns [20,21,32]. For Pvmsp-3α  the
major expected size polymorphisms are: type A (~1.8 -
1.9 kb), type B (~1.4 - 1.5 kb) and type C (~1.1 - 1.2 kb)
[27,31-33]. Conversely, apart from type C which is sub-
stantially smaller (~0.65 kb), the expected undigested
type A (1.7 - 2.2 kb) and type B (1.4 - 1.5 kb) alleles for
Pvmsp-3β  [20] are in similar size ranges to those of
Pvmsp-3α. Mixed-clone infections were diagnosed when
amplification of a single sample resulted in PCR products
of different sizes, or where the summation of the lengths
of the digested amplicons exceeded the size of the undi-
gested PCR product [21]. To score the combined fre-
quency of mixed-clone infections based on restriction
data for both Pvmsp-3α and Pvmsp-3β genes, a sample
which showed mixed genotypes at both genes was scored
as mixed, while a sample which was monoclonal at one
gene but mixed at the other was also scored as mixed in
the final tally. Only if a sample was monoclonal at both
genes was it counted as monoclonal in the final, com-
bined data tally.
PCR analysis of Pfmsp-1 and Pfmsp-2 genes in P. falciparum
Plasmodium falciparum genotyping was carried out on
the polymorphic block 2 of the msp-1 gene on chromo-
some 9, and on block 3 of the msp-2 gene on chromo-
some 2, using previously reported nested PCR conditions
[17], with some modifications. In the primary reaction,
primer pairs corresponding to the conserved sequences
spanning the polymorphic regions of the two genes were
included (Table 1). For a total reaction volume of 25 μl,
20.2 μl of 1.1× PCR master mix (Thermo Scientific
ABgene, Rochester, NY) was used, together with 0.25 μl
of 10 μM of each of primer, 0.3 μl of Taq polymerase (5 U/
μl), 1.0 μl of 25 mM MgCl2 and 3.0 μl of DNA extract.
Using the product generated in the first reaction as a tem-
plate, five separate secondary reactions were performedKhatoon et al. Malaria Journal 2010, 9:112
http://www.malariajournal.com/content/9/1/112
Page 4 of 10
Table 1: Sequences of the primers used to amplify the Pvmsp-3α and Pvmsp-3β genes of Plasmodium vivax and the Pfmsp-
1 and Pfmsp-2 genes of Plasmodium falciparum isolates from Bannu district, Pakistan.
Gene (PCR reaction)§ Primers* PCR cycling conditions** Reference
P. vivax
Pvmsp-3α (N1) F: 5'-CAGCAGACACCATTTAAGG-3' 95°C 3 min/[94°C 30 s, 54°C 30 s, 68°C 
2.5 min] × 35 cycles, 68°C 5 min
[19]
R: 5'-CCGTTTGTTGATTAGTTGC-3'
Pvmsp-3α (N2) F: 5'-GACCAGTGTGATACCATTAACC-3' 95°C 3 min/[94°C 30 s, 55°C 30 s, 68°C 
2.5 min] × 30 cycles, 68°C 5 min
[19]
R: 5'-ATACTGGTTCTTCGTCTTCAGG-3'
Pvmsp-3β (N1) F: 5'-GTATTCTTCGCAACACTC-3' 95°C 3 min/[94°C 30 s, 54°C 30 s, 68°C 
2.5 min] × 35 cycles, 68°C 5 min
[20]
R: 5'-CTTCTGATGTTATTTCCAG-3'
Pvmsp-3β (N2) F: 5'-CGAGGGGCGAAATTGTAAACC-3' 95°C 3 min/[94°C 30 s, 55°C 30 s, 68°C 
2.5 min] × 30 cycles, 68°C 5 min
[20]
R: 5'-GCTGCTTCTTTTGCAAAGG-3'
P. falciparum
Pfmsp-1 (N1) F: 5'-CTAGAAGCTTTAGAAGATGCAGTATTG-3' 95°C 5 min/[94°C 30 s, 55°C 30 s, 72°C 
1 min] × 35 cycles, 72°C 5 min
[17]
R: 5'-CTTAAATAGTATTCTAATTCAAGTGGATCA-3'
K1 family (N2) F: 5'-AAATGAAGAAGAAATTACTACAAAAGGTGC-3' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5'-GCTTGCATCAGCTGGAGGGCTTGCACCAGA-3'
MAD20 family (N2) F: 5 '-AAATGAAGGAACAAGTGGAACAGCTGTTAC-3 ' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5 '-ATCTGAAGGATTTGTACGTCTTGAATTACC-3 '
RO33 family (N2) F: 5 '-TAAAGGATGGAGCAAATACTCAAGTTGTTG-3 ' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5 '-CATCTGAAGGATTTGCAGCACCTGGAGATC-3 '
Pfmsp-2 (N1) F: 5 '-ATGAAGGTAATTAAAACATTGTCTATTATA-3 ' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5'-CTTTGTTACCATCGGTACATTCTT-3'
FC27 family (N2) F: 5'-AATACTAAGAGTGTAGGTGCARATGCTCCA-3' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5 '-TTTTATTTGGTGCATTGCCAGAACTTGAAC-3 '
3D7/IC family (N2) F: 5 '-AGAAGTATGGCAGAAAGTAAKCCTYCTACT-3 ' 95°C 5 min/[94°C 30 s, 56°C 30 s, 72°C 
45 s] × 30 cycles, 72°C 5 min
[17]
R: 5 '-GATTGTAATTCGGGGGATTCAGTTTGTTCG-3 '
§ N1 = Nest 1 (Primary) reaction; N2 = Nest 2 (Secondary) PCR reaction
* F= Forward primer; R = Reverse primer. The reference sources of the primers are indicated.
**The cycling conditions have been modified in the present work.Khatoon et al. Malaria Journal 2010, 9:112
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using, in each case, a family-specific primer pair (Table 1)
in order to determine the presence of allelic variants from
the MAD20, Kl and RO33 families of msp-1, and the
FC27 and 3D7/IC families of msp-2. In the secondary
reaction, 21.2 μl of 1.1× PCR master mix were used along
with 0.25 μl of 10 μM of each of primer, 1.0 μl of 25 mM
MgCl2, 0.3 μl of Taq polymerase (5 U/μl) and 2.0 μl of the
primary reaction PCR product. Products were run on
ethidium bromide-stained 2.0% agarose gels, and visual-
ized under UV light. The allelic variants of the P. falci-
parum isolates were easily resolved on the agarose gels,
because the primers used are strictly specific to the
respective Pfmsp families, and they bear the additional
advantage of not amplifying with other Plasmodium spe-
cies or human DNA [17]. In all cases, gel documentation
was carried out using Kodak Digital Science 1D Image
Analysis Software version 2.03.
Results
A total of 114 blood samples were collected during the
four-months sampling period, but 17 samples were
excluded from further analysis after being confirmed to
be parasite-free by PCR analysis. The participants (42
female, 72 male), aged 1-60 years, were all local, Pakistani
residents of Bannu, with no known history of travel out-
side Bannu or anti-malarial treatment within two weeks
prior to blood sampling.
Size polymorphism of P. vivax Pvmsp-3α and Pvmsp-3β 
genes
Fifty P. vivax samples successfully amplified at Pvmsp-3α.
Four distinct allele size polymorphisms were observed at
Pvmsp-3α, with 82% (41/50) isolates having allele sizes 1.9
kb (type A), 6% (3/50) with the 1.5 kb fragment (type B),
8% (4/50) with the 1.2 kb fragment (type C), 2% (1/50)
with the 0.3 kb fragment (type D) (Figure 2). One isolate
(2%) exhibited mixed-strain infection. To obtain a higher
resolution on infection diversity, the PCR fragments were
digested the using AluI and HhaI enzymes. Restriction
digestion of the Pvmsp-3α PCR product with AluI yielded
12 different alleles designated as A1-A7, B1, B2, C1, C2
and D (Figure 2); allele A3 being the most abundant (24%;
Table 2). Conversely, restriction with HhaI produced 10
alleles denoted as A1-A6, B1, B2, C1, and D (Figure 2);
allele A5 being the most abundant (22%). Two samples
(4%) remained undigested by HhaI, while 6% isolates
showed mixed-strain infections (Table 2). A comparative
analysis of both AluI and HhaI RFLP patterns showed a
total of 12 different alleles in the 50 samples typed at the
Pvmsp-3α locus, with mixed-strain infections occurring
in 8% (4/50) of the samples.
Thirty-nine P. vivax samples amplified for the Pvmsp-
3β gene. Amplification resulted in two major allele poly-
morphisms, type A (1.7-2.2 kb) in 62% isolates, and type
B (1.4-1.5 kb) in 33% isolates, while 5% of the isolates had
mixed genotypes. A total of 8 restriction patterns, desig-
nated A1-A5 and B1-B3, were obtained following ampli-
con digestion with PstI (Figure 3 and Table 2). Alleles A2
(13%; 5/39) and A3 (13%; 5/39) were the most prevalent
among the samples analysed at Pvmsp-3β. Restriction
analysis of the PCR products provided a higher resolution
of the infection complexity, revealing that 18% of the
samples analysed at the Pvmsp-3β gene exhibited mixed-
strain infection, up from the 5% mixed infections
detected without restriction analysis (Table 2). Overall,
10 out of the 50 P. vivax samples analysed (20%) had
m i x e d - s t r a i n  i n f e c t i o n s  ( t h r e e  d e t e c t e d  b y  P v m s p - 3 α
analysis only, six by Pvmsp-3β analysis only, and one
detected as mixed in both genes).
Size polymorphism of P. falciparum Pfmsp-1 and Pfmsp-2 
genes
A high level of diversity was observed among P. falci-
parum samples. Overall, 9 Pfmsp-1 alleles and 10 Pfmsp-2
alleles were detected. At the Pfmsp-1 locus, 2 K1 family
alleles (170-220 bp), 6 MAD20 alleles (100-250 bp), and 1
RO33 allele (200 bp) were obtained. One of the P. falci-
parum samples did not amplify at either locus despite
repeated amplification, hence 25 samples were geno-
typed. Of these, 84% (21/25) samples successfully ampli-
fied at Pfmsp-1, while 92% (23/25) samples amplified at
Pfmsp-2. A total of 19% (4/21) samples exhibited mixed-
strain infections at Pfmsp-1 (Table 3).
At locus Pfmsp-2, three FC27 alleles (250-500 bp) and
seven 3D7/IC alleles (400-800 bp) were detected. The
3D7/IC genotype was predominant, constituting 65%
(15/23) of the samples, while 9% (2/23) of the samples
exhibited mixed-strain infections at the Pfmsp-2  gene
(Table 3). All except two of the samples that amplified at
Pfmsp-1 were successfully amplified at Pfmsp-2. A com-
parative analysis of both the genotype data for Pfmsp-1
and Pfmsp-2 genes showed that overall, 24% (6/25) P. fal-
ciparum samples exhibited mixed-strain infections.
Discussion
Malaria is a major health problem in Pakistan, and the sit-
uation is not helped by the fact that it shares borders with
countries like Afghanistan, India and southern Iran,
where the disease is also highly endemic. Moreover, there
is substantial cross-border human migration within this
region, exacerbated by upheavals in places like Afghani-
stan that lead to refuge influxes, all of which facilitate
malaria transmission. The introduction of new alleles by
mutation, migration and recombination generates genetic
diversity in natural populations, while the immune
responses of the human host, as well as chemotherapy
play key roles in selection, which affects the frequency of
new alleles in parasite populations [33]. Analyses ofKhatoon et al. Malaria Journal 2010, 9:112
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genetic diversity can therefore give important clues on a
parasite's response to human interventions like drugs or
vaccines, because directional selection will favour the fix-
ation of advantageous alleles in the population, thereby
reducing genetic diversity [34]. Despite its importance,
data on the genetic diversity of the two key malaria para-
site species circulating in Pakistan are largely lacking, and
there is only one recent study analysing the diversity of P.
vivax in the Federally Administered Tribal Areas (FATA)
of the country [27]. The need for detailed studies of the
nature and extent of Plasmodium population diversity in
this region is, therefore, obvious.
The study participants were all local, Pakistani resi-
dents of Bannu, with no known history of travel outside
the district, but fact that the area has a high influx of refu-
gees from Afghanistan as well as being a commercial hub
Table 2: Distribution of Plasmodium vivax msp-3α allele frequencies as determined by the PCR-RFLP method.
Digestion with AluI
(n = 50)
Digestion with HhaI (n = 50) Digestion with PstI
(n = 39)
Gene Allele Frequency Allele Frequency Gene Allele Frequency
msp-3α* A1 8% (4/50) A1 8% (4/50) msp-3β A1 8% (3/39)
A2 20% (10/50) A2 12% (6/50) A2 13% (5/39)
A3 24% (12/50) A3 20% (10/50) A3 13% (5/39)
A4 8% (4/50) A4 6% (3/50) A4 10% (4/39)
A5 12% (6/50) A5 22% (11/50) A5 5% (2/39)
A6 6% (3/50) A6 6% (3/50) B1 8% (3/39)
A7 4% (2/50) B1 4% (2/50) B2 5% (2/39)
B1 2% (1/50) B2 4% (2/50) B3 5% (2/39)
B2 4% (2/50) C1 6% (3/50) U 15% (6/39)
C1 2% (1/50) D 2% (1/50) M 18% (7/39)
C2 6% (3/50) U 4% (2/50)
D 2% (1/50) M 6% (3/50)
M2 %  ( 1 / 5 0 )
*Digested with two enzymes in order to improve the sensitivity of detecting diversity at this locus [19].
U: Uncut
M: Mixed genotype
Figure 2 Major merozoite surface protein-3α alleles identified by PCR and digestion with Alu I and Hha I restriction enzymes in the Plasmo-
dium vivax population from Bannu district, Pakistan. Lane 1 = 50 bp, 2 = 1 Kb, and 3 = 100 bp DNA marker. A, B, C = Undigested PCR products. 
A1, A2 ... are allele types revealed by digestion of the respective PCR products with AluI, while a1, a2 ... are the allele types obtained by digestion with 
HhaI, and M = mixed genotype. Frequencies of these alleles are presented in Table 2.Khatoon et al. Malaria Journal 2010, 9:112
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for central Asia cannot preclude them from being
infected with diverse parasite strains from other geo-
graphical areas. Moreover, while it cannot be stated with
absolute certainty that none of the participants had expo-
sure to anti-malarial drugs, because no drug assays were
carried out, there was no sufficient reason to expect self
medication, since the patients had access to free diagnosis
and treatment through the Malaria Control Program at
the Bannu Hospital. Moreover, relatively high levels of
infection complexity were observed, implying that any
possible contribution of drugs to reducing the observed
diversity may have been insignificant. In particular, high
levels of polymorphism were observed in the potential
vaccine candidate antigens in P. vivax and P. falciparum
isolates from Bannu. In this study, four distinct sizes of
PCR products (A, B, C and D) for Pvmsp-3α  were
detected, while in Thailand [21], Afghanistan [26], and
the FATA of Pakistan [27], only 3 allele sizes (A, B and C)
were obtained for this gene. The present finding, by AluI
digestion of Pvmsp-3α amplicons, that allele group A was
most prevalent is consistent with observations from the
FATA of Pakistan [27], Venezuelan Amazon [33], Papua
New Guinea [19], Afghanistan and southern Iran (with
which Pakistan shares a common border); but it differs
from hypo-endemic northern Iran where type C of the
Pvmsp-3α gene is predominant [26,32]. Overall, like in
Figure 3 Major merozoite surface protein-3β alleles identified by PCR and digestion with Pst I restriction enzymes in the Plasmodium vivax 
population from Bannu district, Pakistan. Lane 1 = 50 bp, 2 = 1 Kb, and 3 = 100 bp DNA marker. A, B, C = Undigested PCR products. A1, A2 ... are 
allele types revealed by digestion of the respective PCR products with PstI, while M = mixed genotype. Frequencies of these alleles are presented in 
Table 2.
Table 3: Allelic distribution of Pfmsp-1 and Pfmsp-2 among Pakistani Plasmodium falciparum isolates from Bannu district, 
Pakistan.
Gene* Genotype Frequency
Pfmsp-1 (n = 21) K1 5% (1/21)
MAD20 67% (14/21)
RO33 9% (2/21)
K1+MAD20 14% (3/21)
MAD20+RO33 5% (1/21)
Pfmsp-2 (n = 23) 3D7/IC 65% (15/23)
FC27 26% (6/23)
FC27+3D7/IC 9% (2/23)
*A total of 25 samples were genotyped. All except two of the samples that amplified at Pfmsp-1 were amplified at the Pfmsp-2 gene.Khatoon et al. Malaria Journal 2010, 9:112
http://www.malariajournal.com/content/9/1/112
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Iran and Afghanistan, the Pvmsp-3α  gene was highly
polymorphic in Pakistan. In addition to the three major
alleles, smaller bands (0.45 - 0.57 kb) have occasionally
been amplified in P. vivax strains from other parts of Asia
[18]. A smaller (0.3 kb) allele was detected in Pakistan.
The PCR-RFLP patterns for P. vivax Pvmsp-3β gene
produced 2 categories (A [1.7-2.2 kb] and B [1.4-1.5 kb])
of size polymorphisms, in contrast to Northwest Thai-
land where three distinct allele types (A, B and C [~0.65
kb]) were found [20]. Moreover, 15% of the Pakistani iso-
lates belonging to allele type B did not have any restric-
tion site for PstI, in contrast to Thailand and China where
all type B isolates were digested by PstI [20]. Data from
PCR-RFLP of the Pvmsp-3α and Pvmsp-3β locishowed
that 20% of the Pakistani P. vivax isolates exhibited
mixed-strain infections, which is three-fold higher than
what was observed in Bengbu (China), and is comparable
to sites in Thailand (21%) [20], but lower than the com-
plexity (30%) observed in the FATA region of Pakistan
which directly shares a border with Afghanistan [27]. In
northern Iran [32] and Hongshuihe (China), no mixed
genotypes were detected [20]. Apart from differences in
transmission intensities in various areas, the observed
differences in parasite types could be attributed to factors
such as sampling biases, host immune selective pressure
on particular types and/or spatiotemporal changes in the
availability of different mosquito species that can trans-
mit specific parasite types in a particular area over differ-
ent times or seasons, with areas that share the same
mosquito types tending to have similar parasite types
[27]. As such, comparative studies of P. vivax parasite
types as well as the mosquito species in different areas
during the same season would be interesting.
This study shows high levels of polymorphism at msp-1
(9 alleles) and msp-2 (10 alleles) loci for the P. falciparum
isolates from the Bannu district of Pakistan. Such high
levels of genetic diversity at these two genes mirror what
has been observed in neighbouring Iran [35] and India
[36] where all three families of msp-1 (K1, MAD20 and
RO33) and the two of msp-2 families (FC27 and 3D7/IC)
were amplified, and the MAD20 allelic family was pre-
dominant [37-39]. However, the prevalence of the
K1+MAD20 mixed genotype in India was 54.3% [39],
which is substantially higher (about four-fold) than what
was observed in Pakistan (14%). Furthermore, the Indian
samples showed an over-representation of the 200 bp
allele of MAD20 [36] whereas a shorter (150 bp) MAD20
allele was predominant in the Pakistani samples. For msp-
2, the 3D7/IC alleles were predominant in Pakistan, just
as has been reported in neighbouring Iran [35]. However,
the allele sizes in the Pakistani isolates (400-800 bp for
3D7/IC alleles and 250-500 bp for FC27 alleles) were
larger than those observed in Iran (400-600 bp for 3D7/
IC alleles and 200-400 bp for FC27 alleles). In remarkable
contrast, all P. falciparum isolates from the hypoendemic
French Guiana (South America) were monomorphic at
msp-1 [40] while in Colombia, msp-1 was monomorphic
and msp-2 had only 3 alleles [41]. These results suggest
high spatial heterogeneity of P. falciparum infections,
which may result from geographical isolation, differences
in transmission intensity, and malaria treatment policies.
In particular, geographically isolated parasite populations
are expected to be less diverse than exposed populations,
due to lack of a continuous introduction of new parasite
clones from other areas. Similarly, because of high levels
of inbreeding, areas of low transmission intensity tend to
have less diverse parasites than areas of high endemicity,
where the rates of cross-fertilization are higher [20,42]. In
the same vein, treatment policies that focus on using
highly potent drugs like artemisinin combination thera-
pies (ACTs) that kill the asexual blood stage parasites as
well as gametocytes are more likely to decrease parasite
transmission and clonal diversity than regimens based on
drugs that act only on the blood stage parasites [43,44]. In
Pakistan, monotherapies that work on blood stage para-
site are still largely used, with the key first line malaria
drugs being chloroquine for P. vivax and sulphadoxine-
pyrimethamine (SP) for P. falciparum [4]. Moreover,
recent molecular work shows that parasites in this region
are rapidly developing resistance to these drugs [8], and
worse still, antimalarial drugs like SP are known to trigger
a massive release of gametocytes; the infective stage for
the mosquito vector [44].
Conclusions
In conclusion, this study indicates that both P. vivax and
P. falciparum populations in the Bannu district of Paki-
stan are highly diverse. The high prevalence of mixed-
species and mixed-clone infections in P. falciparum and P.
vivax in Bannu likely results from high transmission and
parasite introduction by human travel. Bannu is basin-
like, and is intersected by two major rivers whose banks
and associated irrigation activities provide ideal breeding
grounds for malaria vectors. Secondly, besides being a
regional commercial hub for Central Asia, the area has a
high influx of Afghan refugees who may also facilitate the
introduction of parasite clones from Afghanistan. Fur-
thermore, mixed-clone infections within the human host
facilitate cross-fertilization, meiotic recombination and
production of novel parasite strains during the sexual
stage in the mosquito vector [20,42,45]. Such heterogene-
ity might thus cause differences in parasite virulence,
transmissibility and responses to chemotherapy, with
important implications for malaria control measures in
this populous region. Imperatively, further studies aimed
at determining the associations between different para-
site genotypes and clinical manifestations of the diseaseKhatoon et al. Malaria Journal 2010, 9:112
http://www.malariajournal.com/content/9/1/112
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might be valuable for future management of the disease
in this area of mixed-species endemicity [27].
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